Deutsche Bank Ag\ Capricor Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$3.8 - $5.23 $551 - $758	-145 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$3.16 - $5.72 $458 - $829	145 New	145 $1,000
Q1 2020 May 14, 2020	SELL	$0.94 - $2.02 $2,039 - $4,383	-2,170 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.04 - $3.55 $2,256 - $7,703	2,170 New	2,170 $2,000

8.18M

1.78M

1.4M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $354M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.